vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and Lifevantage Corp (LFVN). Click either name above to swap in a different company.

Lifevantage Corp is the larger business by last-quarter revenue ($48.9M vs $39.9M, roughly 1.2× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs 0.6%, a 5.0% gap on every dollar of revenue. On growth, HARTE HANKS INC posted the faster year-over-year revenue change (-15.4% vs -27.8%). Lifevantage Corp produced more free cash flow last quarter ($1.7M vs $-686.0K). Over the past eight quarters, Lifevantage Corp's revenue compounded faster (0.7% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Lifevantage Corp is a health and wellness enterprise that develops, manufactures and distributes science-backed nutritional supplements, skincare and personal care products. It operates via a direct-to-consumer network marketing model, serving customers across North America, Europe and the Asia-Pacific, with focus on anti-aging and holistic health solution segments.

HHS vs LFVN — Head-to-Head

Bigger by revenue
LFVN
LFVN
1.2× larger
LFVN
$48.9M
$39.9M
HHS
Growing faster (revenue YoY)
HHS
HHS
+12.4% gap
HHS
-15.4%
-27.8%
LFVN
Higher net margin
HHS
HHS
5.0% more per $
HHS
5.5%
0.6%
LFVN
More free cash flow
LFVN
LFVN
$2.4M more FCF
LFVN
$1.7M
$-686.0K
HHS
Faster 2-yr revenue CAGR
LFVN
LFVN
Annualised
LFVN
0.7%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HHS
HHS
LFVN
LFVN
Revenue
$39.9M
$48.9M
Net Profit
$2.2M
$276.0K
Gross Margin
74.0%
Operating Margin
-0.3%
1.0%
Net Margin
5.5%
0.6%
Revenue YoY
-15.4%
-27.8%
Net Profit YoY
-89.2%
EPS (diluted)
$0.30
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
LFVN
LFVN
Q4 25
$39.9M
$48.9M
Q3 25
$39.5M
$47.6M
Q2 25
$38.6M
$55.1M
Q1 25
$41.6M
$58.4M
Q4 24
$47.1M
$67.8M
Q3 24
$47.6M
$47.2M
Q2 24
$45.0M
$48.9M
Q1 24
$45.4M
$48.2M
Net Profit
HHS
HHS
LFVN
LFVN
Q4 25
$2.2M
$276.0K
Q3 25
$-2.3M
$2.2M
Q2 25
$-335.0K
$2.0M
Q1 25
$-392.0K
$3.5M
Q4 24
$2.5M
Q3 24
$142.0K
$1.8M
Q2 24
$-27.8M
$1.3M
Q1 24
$-171.0K
$1.7M
Gross Margin
HHS
HHS
LFVN
LFVN
Q4 25
74.0%
Q3 25
79.5%
Q2 25
79.9%
Q1 25
81.0%
Q4 24
80.5%
Q3 24
79.9%
Q2 24
79.5%
Q1 24
78.9%
Operating Margin
HHS
HHS
LFVN
LFVN
Q4 25
-0.3%
1.0%
Q3 25
1.3%
4.8%
Q2 25
0.1%
3.9%
Q1 25
-0.1%
6.9%
Q4 24
-3.3%
5.1%
Q3 24
4.0%
5.4%
Q2 24
3.0%
5.9%
Q1 24
0.8%
4.0%
Net Margin
HHS
HHS
LFVN
LFVN
Q4 25
5.5%
0.6%
Q3 25
-5.8%
4.5%
Q2 25
-0.9%
3.6%
Q1 25
-0.9%
5.9%
Q4 24
3.8%
Q3 24
0.3%
3.9%
Q2 24
-61.8%
2.7%
Q1 24
-0.4%
3.4%
EPS (diluted)
HHS
HHS
LFVN
LFVN
Q4 25
$0.30
$0.02
Q3 25
$-0.31
$0.17
Q2 25
$-0.05
$0.16
Q1 25
$-0.05
$0.26
Q4 24
$-0.31
$0.19
Q3 24
$0.02
$0.14
Q2 24
$-3.84
$0.10
Q1 24
$-0.02
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
LFVN
LFVN
Cash + ST InvestmentsLiquidity on hand
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$33.0M
Total Assets
$91.8M
$61.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
LFVN
LFVN
Q4 25
$5.6M
Q3 25
$6.5M
Q2 25
$4.8M
$20.2M
Q1 25
$9.0M
Q4 24
$9.8M
Q3 24
$5.9M
Q2 24
$11.0M
$16.9M
Q1 24
$11.5M
Stockholders' Equity
HHS
HHS
LFVN
LFVN
Q4 25
$20.5M
$33.0M
Q3 25
$19.9M
$33.2M
Q2 25
$22.2M
$34.6M
Q1 25
$21.4M
$34.0M
Q4 24
$21.7M
$29.9M
Q3 24
$21.0M
$27.7M
Q2 24
$20.6M
$26.0M
Q1 24
$20.0M
$26.8M
Total Assets
HHS
HHS
LFVN
LFVN
Q4 25
$91.8M
$61.2M
Q3 25
$92.7M
$61.6M
Q2 25
$95.0M
$72.0M
Q1 25
$100.6M
$77.2M
Q4 24
$101.8M
$68.5M
Q3 24
$108.1M
$61.5M
Q2 24
$109.7M
$60.3M
Q1 24
$113.4M
$61.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
LFVN
LFVN
Operating Cash FlowLast quarter
$737.0K
$2.8M
Free Cash FlowOCF − Capex
$-686.0K
$1.7M
FCF MarginFCF / Revenue
-1.7%
3.5%
Capex IntensityCapex / Revenue
3.6%
2.2%
Cash ConversionOCF / Net Profit
0.33×
10.11×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$1.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
LFVN
LFVN
Q4 25
$737.0K
$2.8M
Q3 25
$3.2M
$-2.3M
Q2 25
$-4.8M
$1.0M
Q1 25
$-818.0K
$2.2M
Q4 24
$4.0M
$9.2M
Q3 24
$-2.9M
$-583.0K
Q2 24
$1.6M
$2.6M
Q1 24
$-5.7M
$3.1M
Free Cash Flow
HHS
HHS
LFVN
LFVN
Q4 25
$-686.0K
$1.7M
Q3 25
$2.2M
$-2.7M
Q2 25
$-5.1M
$835.0K
Q1 25
$-923.0K
$1.9M
Q4 24
$3.4M
$8.7M
Q3 24
$-4.9M
$-932.0K
Q2 24
$926.0K
$2.3M
Q1 24
$-6.2M
$2.8M
FCF Margin
HHS
HHS
LFVN
LFVN
Q4 25
-1.7%
3.5%
Q3 25
5.5%
-5.8%
Q2 25
-13.1%
1.5%
Q1 25
-2.2%
3.2%
Q4 24
7.3%
12.8%
Q3 24
-10.2%
-2.0%
Q2 24
2.1%
4.7%
Q1 24
-13.7%
5.8%
Capex Intensity
HHS
HHS
LFVN
LFVN
Q4 25
3.6%
2.2%
Q3 25
2.5%
0.9%
Q2 25
0.6%
0.4%
Q1 25
0.3%
0.6%
Q4 24
1.3%
0.7%
Q3 24
4.0%
0.7%
Q2 24
1.5%
0.6%
Q1 24
1.2%
0.6%
Cash Conversion
HHS
HHS
LFVN
LFVN
Q4 25
0.33×
10.11×
Q3 25
-1.07×
Q2 25
0.53×
Q1 25
0.64×
Q4 24
3.61×
Q3 24
-20.76×
-0.32×
Q2 24
1.98×
Q1 24
1.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

LFVN
LFVN

Segment breakdown not available.

Related Comparisons